These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28301380)

  • 1. Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle.
    Mao H; Du Y; Zhang Z; Cao B; Zhao J; Zhou H; Mao X
    Anticancer Drugs; 2017 Apr; 28(4):376-383. PubMed ID: 28301380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
    Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
    Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer.
    Yu JG; Ji CH; Shi MH
    Kaohsiung J Med Sci; 2019 Apr; 35(4):202-208. PubMed ID: 30896891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
    Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
    Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
    Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
    Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM25 has a dual function in the p53/Mdm2 circuit.
    Zhang P; Elabd S; Hammer S; Solozobova V; Yan H; Bartel F; Inoue S; Henrich T; Wittbrodt J; Loosli F; Davidson G; Blattner C
    Oncogene; 2015 Nov; 34(46):5729-38. PubMed ID: 25728675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
    Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
    Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
    Qin X; Qiu F; Zou Z
    Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
    Qin Y; Cui H; Zhang H
    Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
    Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Trim25 in development, disease and RNA metabolism.
    Heikel G; Choudhury NR; Michlewski G
    Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.
    Sun N; Xue Y; Dai T; Li X; Zheng N
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28620119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.
    Nasrullah U; Stanke K; Recknagel V; Bozkurt S; Wurzel P; Gauer S; Imre G; Münch C; Pfeilschifter J; Eberhardt W
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All Paths Lead to TRIM25.
    Zhou H; Costello JC
    Trends Cancer; 2017 Oct; 3(10):673-675. PubMed ID: 28958384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.
    Walsh LA; Alvarez MJ; Sabio EY; Reyngold M; Makarov V; Mukherjee S; Lee KW; Desrichard A; Turcan Ş; Dalin MG; Rajasekhar VK; Chen S; Vahdat LT; Califano A; Chan TA
    Cell Rep; 2017 Aug; 20(7):1623-1640. PubMed ID: 28813674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells.
    Li YH; Zhong M; Zang HL; Tian XF
    Exp Cell Res; 2018 Oct; 371(1):250-254. PubMed ID: 30118695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases.
    Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG
    PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
    Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
    Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.